vs
Side-by-side financial comparison of SOLENO THERAPEUTICS INC (SLNO) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $35.3M, roughly 1.9× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs 39.4%, a 4.5% gap on every dollar of revenue. UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $43.5M).
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
SLNO vs UNTY — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.0M | $35.3M |
| Net Profit | $26.0M | $15.5M |
| Gross Margin | 98.3% | — |
| Operating Margin | 33.5% | 55.8% |
| Net Margin | 39.4% | 43.9% |
| Revenue YoY | — | 24.2% |
| Net Profit YoY | 134.0% | 34.5% |
| EPS (diluted) | $0.47 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $35.3M | ||
| Q3 25 | $66.0M | $32.8M | ||
| Q2 25 | $32.7M | $34.4M | ||
| Q1 25 | — | $29.4M | ||
| Q4 24 | — | $28.4M | ||
| Q3 24 | — | $27.7M | ||
| Q2 24 | — | $25.5M | ||
| Q1 24 | — | $25.6M |
| Q4 25 | — | $15.5M | ||
| Q3 25 | $26.0M | $14.4M | ||
| Q2 25 | $-4.7M | $16.5M | ||
| Q1 25 | — | $11.6M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | — | $10.9M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | — | $9.6M |
| Q4 25 | — | — | ||
| Q3 25 | 98.3% | — | ||
| Q2 25 | 97.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 55.8% | ||
| Q3 25 | 33.5% | 57.5% | ||
| Q2 25 | -20.0% | 62.6% | ||
| Q1 25 | — | 52.6% | ||
| Q4 24 | — | 51.0% | ||
| Q3 24 | — | 52.7% | ||
| Q2 24 | — | 49.3% | ||
| Q1 24 | — | 50.0% |
| Q4 25 | — | 43.9% | ||
| Q3 25 | 39.4% | 43.8% | ||
| Q2 25 | -14.4% | 48.0% | ||
| Q1 25 | — | 39.5% | ||
| Q4 24 | — | 40.5% | ||
| Q3 24 | — | 39.4% | ||
| Q2 24 | — | 37.1% | ||
| Q1 24 | — | 37.5% |
| Q4 25 | — | $1.52 | ||
| Q3 25 | $0.47 | $1.41 | ||
| Q2 25 | $-0.09 | $1.61 | ||
| Q1 25 | — | $1.13 | ||
| Q4 24 | — | $1.13 | ||
| Q3 24 | — | $1.07 | ||
| Q2 24 | — | $0.92 | ||
| Q1 24 | — | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $498.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $494.8M | $345.6M |
| Total Assets | $599.9M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $498.9M | — | ||
| Q2 25 | $286.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $345.6M | ||
| Q3 25 | $494.8M | $334.0M | ||
| Q2 25 | $240.1M | $319.8M | ||
| Q1 25 | — | $306.1M | ||
| Q4 24 | — | $295.6M | ||
| Q3 24 | — | $284.3M | ||
| Q2 24 | — | $273.4M | ||
| Q1 24 | — | $266.8M |
| Q4 25 | — | $3.0B | ||
| Q3 25 | $599.9M | $2.9B | ||
| Q2 25 | $332.3M | $2.9B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.5M | $44.9M |
| Free Cash FlowOCF − Capex | $43.5M | $44.3M |
| FCF MarginFCF / Revenue | 65.8% | 125.7% |
| Capex IntensityCapex / Revenue | 0.0% | 1.6% |
| Cash ConversionOCF / Net Profit | 1.67× | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | — | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $44.9M | ||
| Q3 25 | $43.5M | $45.5M | ||
| Q2 25 | $-12.6M | $-25.3M | ||
| Q1 25 | — | $17.9M | ||
| Q4 24 | — | $48.0M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | — | $-8.4M | ||
| Q1 24 | — | $15.8M |
| Q4 25 | — | $44.3M | ||
| Q3 25 | $43.5M | $45.3M | ||
| Q2 25 | $-12.6M | $-25.5M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | — | $47.3M | ||
| Q3 24 | — | $17.5M | ||
| Q2 24 | — | $-8.6M | ||
| Q1 24 | — | $15.7M |
| Q4 25 | — | 125.7% | ||
| Q3 25 | 65.8% | 138.1% | ||
| Q2 25 | -38.6% | -74.2% | ||
| Q1 25 | — | 59.9% | ||
| Q4 24 | — | 166.5% | ||
| Q3 24 | — | 63.3% | ||
| Q2 24 | — | -33.7% | ||
| Q1 24 | — | 61.4% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | 1.67× | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
